Navigation Links
Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
Date:12/5/2007

GAITHERSBURG, Md., Dec. 5 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. announced today the selection of PAN-622 -- a fully human sequence monoclonal antibody against HAAH -- as its lead cancer therapeutic product. Developed in collaboration with the Massachusetts Institute of Technology, PAN-622 has demonstrated high affinity and excellent efficacy in animal models of cancer. Having a fully human sequence, PAN-622 is anticipated to have significantly fewer adverse effects compared to chimeric or humanized monoclonal antibodies. Initial human clinical trials with PAN-622 are anticipated to begin in early 2009.

Human Aspartyl (Asparaginyl) Beta-Hydroxylase (HAAH) is an enzyme that modulates signaling factors such as Notch, and is over-expressed in malignant cells. HAAH is present specifically on the cancer cell surface and on the infiltrating edge of tumors; surface expression of HAAH also makes it accessible to drugs or antibodies that are not capable of crossing cellular membranes. Alterations in cellular function due to its overexpression and translocalization are consistent with the cancer phenotype, and include increased cellular proliferation, motility and invasiveness. When HAAH expression is silenced in cancer cells or its enzymatic activity is neutralized on the cell surface, the cancer cells revert to a normal phenotype. HAAH overexpression and its surface expression has been detected in more than 20 different cancer types and in >99% of all tumor samples tested to date (n > 1000). HAAH is not present in significant amounts in adjacent non- transformed tissue as well as normal tissue (n > 500). Therapeutics directed against HAAH, particularly monoclonal antibodies, are likely to be effective in treating a broad range of cancers with minimal adverse effects.

In vitro, Panacea has shown that monoclonal antibodies against HAAH inhibit cell growth in a dose-dependent fashion, inhibit cell motility more than 6-fold and reduce invasion from 2
'/>"/>

SOURCE Panacea Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Bonita ™ Hair Skin and Nail ... many conditions that range from hair breakage and split ... has now developed a single serving, rapid response tablet ... only stronger than the original Bonita formula, but also ... , Justin Zehrung, Vice President of Essential Source ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The ... for Disease Control of the 2500 to 3000 citizens, ... cancer called mesothelioma this year, about one third will ... Navy Veteran diagnosed with this asbestos exposure form of ... them instant access to the nations most skilled mesothelioma ...
(Date:6/19/2013)... 19, 2013 Faith4Kidz is starting a new ... Peace". Faith4Kidz would like help showing support for kids to ... are more positive. Check out the website, http://www.gracenfaith.com ... logo is red, white and blue stars as a symbol ... throughout history as well as the stars we should encourage ...
(Date:6/18/2013)... June 18, 2013 Exposed Skin Care has ... of acne suffers of all ages finally achieve the clear, ... treatment products, this new acne clearing system combines the power ... prevent new acne from forming. , After a ... these products are some of the most effective available on ...
(Date:6/18/2013)... Looking for a way to break out of the ... IWALKAWAKE is a guide to unlocking one’s true potential through ... on harnessing the powerful and abundant spiritual presence that is ... guide to finding one’s true purpose and potential. These nine ... to reach their true potential. The awakenings deal with subjects ...
Breaking Medicine News(10 mins):Health News:Essential Source ® Improves On Best Selling Bonita ™ Hair Skin and Nail Product 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3
... ... BWIN™, and WaveRider® Product Lines , ... (PRWEB) November 6, 2009 -- WAV, Inc., the ... it has partnered with Vecima Networks Inc. (TSX:VCM), a leading provider of equipment ...
... of the National Council on Aging: , WASHINGTON, Nov. 6 ... pass the Affordable Health Care for America Act (H.R. 3962), ... goal of accessible, quality health care for Americans of all ... the bill is a good deal for America,s seniors. H.R. ...
... Lockton Benefit Group, the health and welfare benefits ... employer health cost reduction initiatives through health risk ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090415/CG99351LOGO ) , Lockton ... support Lockton,s clients with: , Health promotion ...
... group of patients with severe Graves, eye disease experienced ... following treatment with the drug rituximab. Inflammation around ... significantly reduced. The same patients had not previously responded ... Raymond S. Douglas, M.D., Ph.D., an oculoplastics specialist ...
... , Award-Winning Company is Maker of The Thermal Angel ... 6 Estill Medical Technologies, a family-owned Texas company that ... Infusion Warmer , was named one of the area,s ... Co-founded by the Caruth Institute for Entrepreneurship in 1990, the ...
... both sides of the Atlantic applaud President Barack Obama ... Union (EU) Presidency, for establishing a transatlantic task force ... that threatens patient safety and public health worldwide. During ... Obama and Prime Minister Reinfeldt joined forces to address ...
Cached Medicine News:Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3Health News:NCOA Supports H.R. 3962, the Affordable Health Care for America Act 2Health News:Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 2Health News:Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 3Health News:Researchers find new way to attack inflammation in Graves' eye disease 2Health News:Life Saving Estill Medical Technologies Receives Prestigious 'Dallas 100(TM)' Award 2Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 2Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 3Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 4
(Date:6/18/2013)... , June 18, 2013 The board ... LLY ) has declared a dividend for the ... outstanding common stock. The dividend is ... the close of business on August 15, 2013. ... growing portfolio of pharmaceutical products by applying the latest ...
(Date:6/18/2013)... 18, 2013 New-generation electronic designs are ... and lightweight. Simultaneously, circuitry is increasing the number ... to which it performs at. Connecting cables from ... military equipment, such as cameras or detectors, must ... nano-circular connectors include custom cable designs for high-quality ...
(Date:6/18/2013)... -- Healthgrades, the leading online resource that helps consumers ... hospitals, today issued the Healthgrades Women,s Health ... to Get Your Best Outcome . The report, which ... gynecologic surgery, as well as hospitals that excelled ... the most common hospital-based conditions and procedures, urges ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4
... CARLOS, Calif., Sept. 21 NeurogesX, Inc.,(Nasdaq: ... enrollment in study,C119, a second Phase 3 clinical ... treatment of painful HIV-distal sensory polyneuropathy,(HIV-DSP). NGX-4010 is ... Previously completed Phase 3 trials demonstrated that a,single, ...
... the American Journal of Nephrology -, DEERFIELD, Ill., ... its Phase III data on VAPRISOL was published in,the ... this study,VAPRISOL showed a significant increase in serum sodium ... that,occurs when the body,s sodium level falls below normal. ...
Cached Medicine Technology:NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 2NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 3NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 2Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 3Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 5
... is a completely new concept ... use of optic technology for ... applying touch-less vibration system (Patent ... ergonomic user friendly, novel design ...
... A human blood based control designed ... needs, from Point of Care Testing (POCT) ... labs. GlycoHemosure is intended as a basic ... procedures for the quantitation of hemoglobin A1c. ...
SPOT RT KE and RT SE digital camera lines provide maximum performance in a mid-line scientific camera system....
... ResMeds premium APAP device in the S8 ... patients pressure needs on a breath-by-breath basis. ... fully integrated humidification and also include remote ... patients time by reducing medical visits. Like ...
Medicine Products: